Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe in High/very High Risk ASCVD Patients

NCT06641661 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT06641661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe in High/very High Risk ASCVD Patients
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
June 30, 2027
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ascvd, gene polymorphism